Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Clarify how the wash-sale rule applies to ETFs, including practical timing, replacement restrictions, and compliant planning.
9,454 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Floating-rate senior loan ETFs can offer roughly 7% yields, producing about $35,000 a year from a $500,000 position. ...
As AI enthusiasm shakes up the tech market, Microsoft stands out as a potentially steadier megacap. This article brea...
Investors eyeing SpaceX pre-IPO opportunities can gain exposure through established AI leaders. This guide explains h...
Snowflake's CEO challenges the traditional org-chart mindset as AI reshapes hiring and teamwork. The market is watchi...
South Korea’s stock market logged a 16% swing in 24 hours as retail investors using leverage intensified trading, fue...
Investors watched airline stocks rise after a key sustainable fuel deal was announced. This piece breaks down the dri...
A top Wall Street CIO says the AI trade is overheating and chart signals warn of a pullback. He urges shifting into e...
A coalition of silicon valley insiders warns that the United States is underprepared for modern warfare, with wide-re...
Bitcoin is nearing a major recalibration as mining margins shrink and industry trackers warn of a double-digit diffic...
A team of researchers behind AI-driven biology raises a $50 million seed round to scale models that read, write, and ...
QTUM has surged ahead of QQQ in the current rally, raising questions about whether a quantum-themed ETF can outpace t...